Correlation Between Metacrine and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Metacrine and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metacrine and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Metacrine and Monopar Therapeutics, you can compare the effects of market volatilities on Metacrine and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metacrine with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metacrine and Monopar Therapeutics.
Diversification Opportunities for Metacrine and Monopar Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Metacrine and Monopar is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Metacrine and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Metacrine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metacrine are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Metacrine i.e., Metacrine and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Metacrine and Monopar Therapeutics
If you would invest 2,385 in Monopar Therapeutics on December 30, 2024 and sell it today you would earn a total of 1,648 from holding Monopar Therapeutics or generate 69.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Metacrine vs. Monopar Therapeutics
Performance |
Timeline |
Metacrine |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Monopar Therapeutics |
Metacrine and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Metacrine and Monopar Therapeutics
The main advantage of trading using opposite Metacrine and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metacrine position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.Metacrine vs. Protara Therapeutics | Metacrine vs. CytomX Therapeutics | Metacrine vs. Assembly Biosciences | Metacrine vs. Instil Bio |
Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |